PD-1/PD-L1-targeted inhibitors play an important role in cancers such as breast cancer, lung cancer, colorectal cancer, gastric cancer, bladder cancer, pancreatic cancer, prostate cancer, DLBCL and so on [10, 13–15]. The gene discussed is PDCD1; the disease is diffuse large B-cell lymphoma.